Transdermal selegiline: new opportunity for managing depression.
Tobe
Edward H
EH
D000279:Administration, Cutaneous; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage*; D012642:Selegiline / Q000008:administration & dosage*
D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline